141 related articles for article (PubMed ID: 12777965)
1. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
[TBL] [Abstract][Full Text] [Related]
2. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans.
Eom SY; Zhang YW; Kim SH; Choe KH; Lee KY; Park JD; Hong YC; Kim YD; Kang JW; Kim H
Cancer Causes Control; 2009 Mar; 20(2):137-45. PubMed ID: 18798003
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
[TBL] [Abstract][Full Text] [Related]
4. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.
Peng XE; Jiang YY; Shi XS; Hu ZJ
Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
[TBL] [Abstract][Full Text] [Related]
6. An association between NQO1 genetic polymorphism and risk of bladder cancer.
Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
[TBL] [Abstract][Full Text] [Related]
7. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.
Basma HA; Kobeissi LH; Jabbour ME; Moussa MA; Dhaini HR
Int J Mol Epidemiol Genet; 2013; 4(4):207-17. PubMed ID: 24319536
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.
Cai L; Zheng ZL; Zhang ZF
World J Gastroenterol; 2005 Mar; 11(12):1867-71. PubMed ID: 15793883
[TBL] [Abstract][Full Text] [Related]
9. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China.
Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W
Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
Hemissi I; Ayed H; Naimi Z; Meddeb K; Ayadi M; Zouari S; Zaghbib S; Talbi E; Chebil M; Ouerhani S
Mol Genet Genomic Med; 2021 Nov; 9(11):e1819. PubMed ID: 34549902
[TBL] [Abstract][Full Text] [Related]
14. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province.
Cai L; Yu SZ; Zhan ZF
World J Gastroenterol; 2001 Dec; 7(6):792-5. PubMed ID: 11854903
[TBL] [Abstract][Full Text] [Related]
17. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
[TBL] [Abstract][Full Text] [Related]
19. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
